These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25732723)

  • 1. Multistate Statistical Modeling: A Tool to Build a Lung Cancer Microsimulation Model That Includes Parameter Uncertainty and Patient Heterogeneity.
    Bongers ML; de Ruysscher D; Oberije C; Lambin P; Uyl-de Groot CA; Coupé VM
    Med Decis Making; 2016 Jan; 36(1):86-100. PubMed ID: 25732723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of modified fractionation radiotherapy versus conventional radiotherapy for unresected non-small-cell lung cancer patients.
    Ramaekers BL; Joore MA; Lueza B; Bonastre J; Mauguen A; Pignon JP; Le Pechoux C; De Ruysscher DK; ; Grutters JP
    J Thorac Oncol; 2013 Oct; 8(10):1295-307. PubMed ID: 24457241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized positron emission tomography-based isotoxic accelerated radiation therapy is cost-effective compared with conventional radiation therapy: a model-based evaluation.
    Bongers ML; Coupé VM; De Ruysscher D; Oberije C; Lambin P; Uyl-de Groot CA
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):857-65. PubMed ID: 25752401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
    Sher DJ; Wee JO; Punglia RS
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e767-74. PubMed ID: 21300476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients.
    Scotti V; Meattini I; Saieva C; Agresti B; de Luca Cardillo C; Bastiani P; Livi L; Mangoni M; Di Cataldo V; Marrazzo L; Rampini A; Cipressi S; Bruni A; Santini P; Biti G
    Radiother Oncol; 2010 Jul; 96(1):84-8. PubMed ID: 20541823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial.
    Krijkamp EM; Alarid-Escudero F; Enns EA; Jalal HJ; Hunink MGM; Pechlivanoglou P
    Med Decis Making; 2018 Apr; 38(3):400-422. PubMed ID: 29587047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage IB nonsmall cell lung cancers: are they all the same?
    Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
    Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer.
    Vaidya M; Creach KM; Frye J; Dehdashti F; Bradley JD; El Naqa I
    Radiother Oncol; 2012 Feb; 102(2):239-45. PubMed ID: 22098794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.
    Puri V; Crabtree TD; Kymes S; Gregory M; Bell J; Bradley JD; Robinson C; Patterson GA; Kreisel D; Krupnick AS; Meyers BF
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):428-36. PubMed ID: 22169443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
    Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of epidermal growth factor receptor tyrosine kinase inhibitors concurrent with individualized radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer.
    Wang J; Xia TY; Wang YJ; Li HQ; Li P; Wang JD; Chang DS; Liu LY; Di YP; Wang X; Wu WZ
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e59-65. PubMed ID: 21345607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swedish lung cancer radiation study group: predictive value of histology for radiotherapy response in patients with non-small cell lung cancer.
    Holgersson G; Bergström S; Bergqvist M; Nyman J; Hoye E; Helsing M; Friesland S; Holgersson M; Birath E; Ekman S; Blystad T; Ewers SB; Mörth C; Löden B; Henriksson R
    Eur J Cancer; 2011 Nov; 47(16):2415-21. PubMed ID: 21726999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
    Chao HH; Berman AT; Simone CB; Ciunci C; Gabriel P; Lin H; Both S; Langer C; Lelionis K; Rengan R; Hahn SM; Prabhu K; Fagundes M; Hartsell W; Mick R; Plastaras JP
    J Thorac Oncol; 2017 Feb; 12(2):281-292. PubMed ID: 27826034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial.
    Westover KD; Loo BW; Gerber DE; Iyengar P; Choy H; Diehn M; Hughes R; Schiller J; Dowell J; Wardak Z; Sher D; Christie A; Xie XJ; Corona I; Sharma A; Wadsworth ME; Timmerman R
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):72-81. PubMed ID: 26279026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
    Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
    Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer.
    Rosen JE; Salazar MC; Wang Z; Yu JB; Decker RH; Kim AW; Detterbeck FC; Boffa DJ
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):44-54.e9. PubMed ID: 27131846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer.
    Stenehjem DD; Bellows BK; Yager KM; Jones J; Kaldate R; Siebert U; Brixner DI
    Oncologist; 2016 Feb; 21(2):196-204. PubMed ID: 26614710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer.
    Higgins KA; O'Connell K; Liu Y; Gillespie TW; McDonald MW; Pillai RN; Patel KR; Patel PR; Robinson CG; Simone CB; Owonikoko TK; Belani CP; Khuri FR; Curran WJ; Ramalingam SS; Behera M
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):128-137. PubMed ID: 27979443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer.
    Oshiro Y; Mizumoto M; Okumura T; Hashimoto T; Fukumitsu N; Ohkawa A; Kanemoto A; Hashii H; Ohno T; Sakae T; Tsuboi K; Sakurai H
    J Thorac Oncol; 2012 Feb; 7(2):370-5. PubMed ID: 22157368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.